Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|June 7, 2021
Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of DementiaJohan Svensson, Maria Blomqvist, Petronella Kettunen, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 11, 2014
Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS SubstudyMaria Bjerke, Michael Jonsson, Arto Nordlund, et al.
Journal of Central Nervous System Disease|June 17, 2014
Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic strokeClara Hjalmarsson, Maria Bjerke, Björn Andersson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 1, 2017
Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sampleMarie Eckerström, Mattias Göthlin, Sindre Rolstad, et al.
Ticks and Tick-Borne Diseases|June 18, 2026
Cognitive outcome in relation to cerebrospinal fluid markers of neuronal and glial cell damage: A prospective study of tick-borne encephalitisMarie Eckerström, Malin Veje, Carl Eckerström, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 18, 2017
Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI StudyErik Hessen, Marie Eckerström, Arto Nordlund, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 30, 2015
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesAnders Wallin, Arto Nordlund, Michael Jonsson, et al.
Journal of Alzheimer'S Disease : JAD|December 7, 2007
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two yearsHenrik Zetterberg, Mona Pedersen, Karin Lind, et al.
Pageof 4